75000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Unaudited Condensed Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Unaudited Condensed Statements of Operations and Comprehensive Loss (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Unaudited Condensed Consolidated Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Unaudited Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Pre-Paid Advance link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Profits Interest Incentive Plan link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Collaboration, License and Option Agreements link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - 401(k) Plan link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - EXUMA Biotech Corp. link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Profits Interest Incentive Plan (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Balance Sheet Details - Schedule Of Prepaid Expenses Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Balance Sheet Details - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Balance Sheet Details - Schedule of Accounts Payable and Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Balance Sheet Details - Schedule of Accounts Payable and Accrued Expenses (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Restructuring (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Restructuring - The changes in the Company's restructuring liability (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Fair Value Measurements - Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Fair Value Measurements - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Fair Value Measurements - Schedule of the Changes in the Fair Value of Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Leases (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Leases - Components of Lease Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Term And Weighted Average Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Leases - Supplemental Cash Flow Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Commitments and Contingencies - Schedule of Expected Future Minimum Payments Under the Non Cancelable Operating Lease (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Pre-Paid Advance (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Stockholders' Equity - Summary of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Stockholders' Equity - Summary of Assumptions Used in Black-Scholes Model (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Stockholders' Equity - Schedule of Common Stock Reserved for Future Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Profits Interest Incentive Plan - Allocation of equity-based Compensation for all class B units (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Profits Interest Incentive Plan (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Collaboration, License and Option Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - 401(k) Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Segment Information - Schedule of Segment expenses reviewed by the CDMO (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - EXUMA Biotech corp. - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Subsequent Events (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Supplemental Cash Flow Information Related to Leases Restructuring Reserve Restructuring Reserve, Ending Balance Restructuring Reserve, Beginning Balance Restructuring Reserve, Total Collaboration, license and option agreements. Collaboration License And Option Agreements [Abstract] Entity incorporation state country code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred Stock, Shares Issued, Total Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Issuance of Series D convertible preferred stock for cash, net of $4,317 of issuance costs, Shares Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2021 (3 months) Plan Name [Axis] Plan Name Equity [Abstract] Entity Current Reporting Status Entity Current Reporting Status Operating Expenses [Abstract] Operating expenses: Level 2 Fair Value, Inputs, Level 2 [Member] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common stock authorized for issuance under plan Document Fiscal Period Focus Document Fiscal Period Focus Debt Instrument, Interest Rate, Stated Percentage Interest rate Entity Shell Company Entity Shell Company Other Accrued Liabilities, Current Other accrued expenses Exclusive license agreement abstract. Exclusive License Agreement [Abstract] Construction in process. Construction In Process [Member] Construction In Process Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalent Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Issuance of Common Stock Under Pre-Paid Advance Agreement, Value Issuance of Common Stock Under Pre-Paid Advance Agreement, Value Issuance of common stock under PPAs, value Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Stock Issued During Period, Shares, Conversion of Units Conversion of Class B common stock, shares Placement Agent Fees Placement Agent Fees Placement agent fees Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock, shares issued (in shares) Asset Class [Domain] Statement [Table] Statement [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Restructuring Charges Included In Accounts Payable and Accrued Expenses Restructuring Charges Included In Accounts Payable and Accrued Expenses Restructuring charges included in accounts payable and accrued expenses purchase common stock through payroll deductions of up to compensations, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Investment Owned, Balance, Principal Amount Remaining outstanding principal balance Statement [Line Items] Statement [Line Items] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Warrant [Member] Warrant [Member] Entity Filer Category Entity Filer Category Pre-Paid Advance Agreement Liability Pre-Paid Advance Agreement Liability PPAs liability PPAs Liability, Beginning Balance PPAs Liability, Ending Balance Liabilities and Equity Total liabilities and stockholders’ equity Debt Instrument [Line Items] Debt Instrument [Line Items] Common Stock Warrants Common stock warrants. Common Sock Wrants [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable Weighted-Average Exercise Price per Share Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Restructuring Costs [Line Items] Restructuring Costs [Line Items] Schedule of the Changes in the Fair Value of liabilities Schedule of the Changes in the Fair Value of liabilities [Table Text Block] Schedule of the Changes in the Fair Value of liabilities [Table Text Block] Restructuring and Related Costs [Table Text Block] Schedule of Changes in Restructuring Liability Proceeds From Issuance Of Common Stock Under Stand by Equity Purchase Agreement Net Proceeds From Issuance Of Common Stock Under Stand by Equity Purchase Agreement Net Proceeds from issuance of common stock under SEPA Number of RSUs unvested on modification date, number of shares Number Of RSUs Unvested On Modification Date, Number of shares Number Of RSUs Unvested On Modification Date, Number of shares Subsequent Event [Line Items] Interest income Investment Income, Interest Modification of Two Thousand Twenty Equity Incentive Plan and certain awards [Member] Modification of Two Thousand Twenty Equity Incentive Plan and certain awards [Member] Modification of Two Thousand Twenty Equity Incentive Plan and certain awards [Member] Effective Business Days Effective Business Days Effective Business Days Accrued Research And Development Includes Related Party Amount Accrued Research And Development Includes Related Party Amount Accrued research and development includes related party amounts Furniture, fixtures and office equipment. Furniture Fixtures And Office Equipment [Member] Furniture Fixtures And Office Equipment Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Liability measured at fair value Property, Plant and Equipment [Line Items] Property Plant And Equipment [Line Items] Cash and Cash Equivalents Restricted Cash Equivalent Restricted Cash Equivalents, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted, Number of Shares 2020 Plan [Member] Two Thousand Twenty Plan [Member] 2020 Plan [Member] percentage of average daily trading volume percentage of average daily trading volume Percentage of average daily trading volume Net loss per common share, basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Retirement Benefits [Text Block] 401(k) Plan Line of Credit Facility, Covenant Terms Covenant Terms Debt Instrument Carrying Amount Percentage Of Face Amount Debt Instrument Carrying Amount Percentage Of Face Amount Purchase price discount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Stock Options Outstanding, Number of Shares Stock Options Outstanding, Number of Shares Stock Options Outstanding, Number of Shares Number of Shares, Ending Balance Number of Shares, Beginning Balance Issuance of common stock for director compensation(shares) Issuance of common stock for director compensation(shares) Issuance of common stock for director compensation, shares Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: 2030 Lessee, Operating Lease, Liability, to be Paid, Year Five Adjustment of warrants per share Adjustment Of Warrants Adjustment Of Warrants Standby Equity Purchase Agreement Fees Standby Equity Purchase Agreement Fees Standby equity purchase agreement fees Payments of Debt Issuance Costs Issuance costs Amendment License Agreement [Member] Amendment License Agreement [Member] Amendment License Agreement [Member] Payments to Acquire Machinery and Equipment Purchases of property and equipment Consolidation Items [Domain] Equity, Attributable to Parent [Abstract] Stockholders' equity (deficit): Entity Small Business Entity Small Business Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Himalaya therapeutics sezc member Himalaya Therapeutics S E Z C [Member] Himalaya Therapeutics SEZC Gain (Loss) On Warrant Liability Gain (Loss) On Warrant Liability Gain on warrant liability Forfeited, Number of Shares Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Facilities And Other [Member] Facilities And Other [Member] Facilities and other Common stock price Sale of Stock, Price Per Share Shares available for awards, description. Shares Available For Awards Description Shares available for awards, description Leases [Abstract] Accrued severance included in accounts payable and accrued expenses Accrued Severance Included in Accounts Payable and Accrued Expenses Accrued Severance Included in Accounts Payable and Accrued Expenses Reduction in Workforce Reduction in Workforce Reduction in workforce Amendment Flag Amendment Flag Amended BeiGene Collaboration. Amended Bei Gene Collaboration [Member] Amended BeiGene Collaboration BeiGene Class of Warrant or Right, Number of Securities Called by Warrants or Rights Purchase of common stock by warrants Basis of Presentation Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Liabilities and Equity [Abstract] Liabilities and Stockholders’ Equity Entity Address, Postal Zip Code Entity Address, Postal Zip Code Partial Conversion of Pre Paid Advance into Common Stock Partial Conversion of Pre Paid Advance into Common Stock Conversion of Pre-Paid Advance into common stock Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Increase (Decrease) in Operating Lease Liability Right-of-use assets and lease liabilities, net ESPP Shares Employees stock purchase plan member. Employees Stock Purchase Plan [Member] Employees Stock Purchase Plan [Member] Warrant For The Purchase Of Common Stock Warrant For The Purchase Of Common Stock Warrants for the purchase of common stock Common Stock [Member] Common Stock Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted, Weighted-Average Exercise Price per Share 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three Issuance of Common Stock Under Standby Equity Purchase Agreement, Shares Issuance of Common Stock Under Standby Equity Purchase Agreement, Shares Issuance of common stock under SEPA, share Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Research and Development Arrangement, Contract to Perform for Others, Type [Domain] License termination information, Description License termination information, Description License termination information, Description Entity Address, Address Line One Entity Address, Address Line One Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Assumptions Used in Black-Scholes Model Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Operating Lease, Right-of-Use Asset Operating lease right-of-use asset, net EXUMA Member. E X U M A [Member] E X U M A Collaboration, license and option agreements text block. Collaboration License And Option Agreements [Text Block] Collaboration, License and Option Agreements Document Type Document Type Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Entity Central Index Key Entity Central Index Key Exclusive license agreement with exuma biotech corp. Exclusive License Agreement With E X U M A Biotech Corp [Text Block] EXUMA Biotech Corp. Fair Value Of Common Stock Related To Pre-Paid Advance Agreement Liabiliity Fair Value Of Common Stock Related To Pre-Paid Advance Agreement Liabiliity Fair value of common stock issued in satisfaction of PPAs liability Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net decrease in cash and cash equivalents Subsequent Event Type [Domain] Fair Value Adjustment of Warrants Change in fair value of warrant liability Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities excluded from calculation of diluted net loss per share Balance Sheet Related Disclosures [Abstract] Liquidity and Going Concern. Liquidity And Going Concern Policy [Text Block] Liquidity and Going Concern Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Company formation date Company Formation Date Company formation date. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding, Weighted-Average Remaining Contractual Term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised, Number of Shares Issuance of common stock upon exercise of options, net, shares Recalculated compensation cost on the modified RSUs Recalculated Compensation Cost On The Modified RSUs Recalculated Compensation Cost On The Modified RSUs Debt Disclosure [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] Amended License Agreement Second Payable Amount Amended License Agreement Second Payable Amount Document Quarterly Report Document Quarterly Report Other prepaid expenses and current assets. Other Prepaid Expenses And Current Assets Other prepaid expenses and current assets Restructuring Costs [Policy Text Block] Restructuring Costs [Policy Text Block] Restructuring Costs Fair Value, by Balance Sheet Grouping [Table] Entity Address, State or Province Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Outstanding Shares, Ending Balance Number of Outstanding Shares, Beginning Balance Operating Leases, Future Minimum Payments, Due Thereafter Thereafter Fair Value, Option, Aggregate Differences, Long-Term Debt Instruments Prepaid aggregate principal amount Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Schedule Of The Change In The Fair Value Of PPAs Liabilities [TableTextBlock] Schedule Of The Change In The Fair Value Of PPAs Liabilities [TableTextBlock] Schedule Of The Change In The Fair Value Of PPAs Liabilities Common Stock, Capital Shares Reserved for Future Issuance Total number of common shares reserved for issuance Operating Leases, Future Minimum Payments, Due in Three Years 2024 Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-Based Compensation Expense Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of options, net Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Debt instrument outstanding principal amount. Debt Instrument Outstanding Principal Amount Debt Instrument Outstanding Principal Amount Interest and Other Income Interest and other income/(expense) Equity Option [Member] Equity Option Subsequent Event [Member] Subsequent Event [Member] Deferred Revenue, Current, Total Deferred Revenue, Current Current portion of deferred revenue Other Assets, Noncurrent, Total Other Assets, Noncurrent Other assets Reimbursement of manufacturing costs. Reimbursement Of Manufacturing Costs Reimbursement Of Manufacturing Costs Antidilutive Securities [Axis] Antidilutive Securities Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Expired, Number of Shares Expired, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested and expected to vest, Aggregate Intrinsic Value Total fair value of options vested Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Related Party Transaction [Axis] Issuance of common stock under SEPA, value Issuance of Common Stock Under Standby Equity Purchase Agreement, Value Issuance of Common Stock Under Standby Equity Purchase Agreement, Value Issuance of common stock for director compensation(value) Issuance of common stock for director compensation(value) Issuance of common stock for director compensation Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Issuance of Series D convertible preferred stock for cash, net of $4,317 of issuance costs Preferred stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 0 shares issued and outstanding at March 31, 2026 and December 31, 2025 Minimum [Member] Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Financial Instrument [Axis] Derivative Asset, Fair Value, Gross Asset, Total Derivative Asset, Subject to Master Netting Arrangement, before Offset Assets measured at fair value Assets, Current [Abstract] Current assets: Common Class B Common Class B [Member] Class B Common Stock Level 3 Fair Value, Inputs, Level 3 [Member] Segment Reporting [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Liabilities, Current [Abstract] Current liabilities: RSUs unvested on modification date, number of shares RSUs Unvested On Modification Date, Number of shares RSUs Unvested On Modification Date, Number of shares Restructuring and Related Activities Disclosure [Text Block] Restructuring Related Party Transactions [Abstract] Total Number of Modified Unvested Restricted Stock Units Total Number of Modified Unvested Restricted Stock Units Total Number of Modified Unvested Restricted Stock Units Shares, Outstanding Ending balance, share Beginning balance, share Commitments and Contingencies Commitments and contingencies (Note 6) Lessee, Leases [Policy Text Block] Leases Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Ending Balance Weighted Average Grant Date Fair Value, Beginning Balance Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total Issuance of common stock under equity incentive plans, net of shares withheld for taxes, shares General and Administrative Expense [Member] General and Administrative Expense Operating Lease, Liability, Total Operating Lease, Liability Total operating lease liabilities Liquidity and Going Concern [Member] Liquidity and Going Concern [Member] Equity-based compensation Equity Based Compensation [Member] Equity Based Compensation [Member] Amendment License Agreement Second [Member] Amendment License Agreement Second [Member] Amendment License Agreement Second [Member] December Two Thousand Twenty Four [Member] December Two Thousand Twenty Four [Member] December 2024 Offering and Warrant Issuance Number of Modified Fully Vested Options Number of Modified Fully Vested Options Number of Modified Fully Vested Options Weighted-average shares of common stock outstanding, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Common stock warrants [Member] Common stock warrants [Member] Common stock warrants Number of options unvested on modification date, number of shares Number Of Options Unvested On Modification Date, Number of shares Number Of Options Unvested On Modification Date, Number of shares Document Information [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Subsequent Events [Text Block] Subsequent Events Context Therapeutics Inc Context Therapeutics Inc Member Context Therapeutics Inc [Member] Related Party Transactions Disclosure [Text Block] Related party transactions APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Ending balances Beginning balances Equity, Attributable to Parent Ending balance Beginning balance Total stockholders’ equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Total Number of Modified Unvested Options Total Number of Modified Unvested Options Total Number of Modified Unvested Options Stock Issued During Period Shares Conversion Of Class B Common Stock Stock Issued During Period Shares Conversion Of Class B Common Stock Conversion of Class B common stock Statement of Stockholders' Equity [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Use of Estimates, Policy [Policy Text Block] Use of Estimates Common shares authorized for issuance Common shares authorized for issuance. Common Shares Authorized for Issuance Leasehold Improvements [Member] Leasehold Improvements Fair Value Disclosures [Text Block] Fair Value Measurements Noncash Investing and Financing Items [Abstract] Supplemental disclosure of non-cash investing and financing activities Plan Name [Domain] Plan Name Collaboration Amendment Date Collaboration agreement start date. Collaboration Agreement Start Date Interest Expense, Total Interest Expense, Operating and Nonoperating Interest Payable Interest expense Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Stock Issued During Period, Value, Other Issuance of common stock under equity incentive plans, net of shares withheld for taxes Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Vesting terms, description Percentage of Annual increased Shares Percentage of Annual increased Shares Settlement Liabilities, Current Settlement of principal and accrued interest Evalstotug, BA3071 Evalstotug BA Three Zero Seven One [Member] Evalstotug BA Three Zero Seven One [Member] Entity Address, City or Town Entity Address, City or Town Debt [Member] Outstanding Debt [Member] Security Exchange Name Security Exchange Name Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross Property, plant and equipment, gross Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest, Number of Shares Merger and Related Share Consolidation Merger And Related Share Consolidation Policy TextBlock Merger And Related Share Consolidation Policy TextBlock Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Two thousand twenty equity incentive plan. Two Thousand Twenty Equity Incentive Plan [Member] 2020 Equity Incentive Plan [Member] Stockholders' Equity Note [Abstract] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Compensation Cost for the Modified Unvested Options Compensation Cost for the Modified Unvested Options Compensation Cost for the Modified Unvested Options Statistical Measurement [Domain] Statistical Measurement Warrants excercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Assets, Current Total current assets Share-Based Payment Arrangement, Expense Equity-based compensation expense Equity-based compensation expense Document Period End Date Document Period End Date Title and Position [Axis] Title of Individual Fair Value Hierarchy and NAV [Domain] Defined Contribution Plan, Cost Contributions made by company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable, Number of Shares Exercisable, Number of Shares Personnel and related Personnel And Related [Member] Personnel And Related [Member] Accrued Salaries, Current Accrued compensation Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) Restricted Stock Units and Stock Options Restricted Stock Units (RSUs) [Member] Antidilutive Security, Excluded EPS Calculation [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Class of Stock [Axis] Class of Stock Lessor Operating Leases Option To Extend. Lessor Operating Leases Option To Extend Liabilities Liabilities Total liabilities Recalculated compensation cost of the modified options Recalculated Compensation Cost Of The Modified Options Recalculated Compensation Cost Of The Modified Options Common stock options and restricted stock units. Common Stock Options and Restricted Stock Units [Member] Financial Instruments [Domain] Gain Loss On Pre-Paid Advance Agreement Liability Gain Loss On Pre-Paid Advance Agreement Liability Gain on PPAs liability Lessee, Operating Lease, Liability, to be Paid, Year Two 2027 Organization. Organization Policy [Text Block] Organization Weighted-average shares of common stock outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Total Program Expenses [Member] Total Program Expenses [Member] Total program expenses Securities Act File Number Entity File Number Class of Warrant or Right, Outstanding and Exercisable Class of Warrant or Right, Outstanding and Exercisable Class of Warrant or Right, Outstanding and Exercisable Cover [Abstract] Other Expenses Other expense Other expense Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of Shares, Forfeited Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum Supplemental Balance Sheet Disclosures [Text Block] Balance Sheet Details Sale of Stock [Domain] Sale of Stock Segment Reporting Disclosure [Text Block] Segment Information General and administrative expense (includes related party amounts of $0 and $[ ], respectively) General and Administrative Expense, Total General and Administrative Expense General and administrative expense Pre-Paid Advance Pre-Paid Advance Pre-Paid Advance Increase in issuance of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period Subsequent Event [Table] Schedule of common stock reserved for future issuance. Schedule Of Common Stock Reserved For Future Issuance Table [Text Block] Schedule of Common Stock Reserved for Future Issuance Stock Issued During Period, Shares, Other Issuance of common stock under equity incentive plans, net of shares withheld for taxes, shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest, Weighted-Average Exercise Price per Share Restructuring Charges Restructuring Charges Restructuring charges Number Of Share Sold Number Of Share Sold SEPA Shares were sold Property, Plant and Equipment, Useful Life Property plant and equipment useful life New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Maturities of Operating Lease Liabilities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Compensation Cost for the Modified Unvested Restricted Stock Units Compensation Cost for the Modified Unvested Restricted Stock Units Compensation Cost for the Modified Unvested Restricted Stock Units Organization And Summary Of Significant Accounting Policies [Line Items] Organization And Summary Of Significant Accounting Policies [Line Items] Organization and Summary of Significant Accounting Policies. Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Organization and Summary of Significant Accounting Policies Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Operating Lease, Liability, Current Operating lease liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Depreciation, Depletion and Amortization, Total Depreciation, Depletion and Amortization Depreciation and amortization Document Transition Report Document Transition Report Total operating expenses Operating Expenses Research and Development Expense, Total Research and Development Expense Research and development expense (includes related party amounts of $1,775 and $2,025 for the three and nine months ended September 30, 2024 and $0 and $125 for the three and nine months ended September 30, 2023, respectively) Research and development expense Lessee, Operating Leases [Text Block] Leases Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Statement of Cash Flows [Abstract] Schedule of Interest Rate Derivatives [Table Text Block] Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rate Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement [Member] Stock Issued During Period, Value, New Issues Issuance of common stock, net of issuance costs Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity 2022 Operating Leases, Future Minimum Payments Due, Next 12 Months Equity [Text Block] Stockholders' Equity Pre-Paid Advance Agreement PPAs [Member] Pre-Paid Advance Agreement PPAs [Member] PPAs [Member] Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Units Consolidated net loss and comprehensive loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding, Aggregate Intrinsic Value Outstanding, Aggregate Intrinsic Value Pre-Paid Advance Remaining Principal Amount Pre-Paid Advance Remaining Principal Amount Operating Lease, Cost Operating lease expense Warrants and Rights Outstanding, Term Warrants and Rights OutstandingTerm Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Dividend yield Operating Lease, Payments Cash paid for amounts included in the measurement of operating leases Assets [Abstract] Assets Awards Available For Future Issuance Under The Two Thousand Twenty Plan Awards Available For Future Issuance Under The Two Thousand Twenty Plan Awards available for future issuance under the 2020 Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Risk-free rate Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Document Fiscal Year Focus Document Fiscal Year Focus Upfront non-refundable payment. Upfront Non Refundable Payment Upfront Non-Refundable Payment Taxes related to net share settlement of equity awards Taxes related to net share settlement of equity awards Taxes related to net share settlement of equity awards Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Retirement Benefits [Abstract] Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Accounts payable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Total fair value of options vested Research and Development Expense [Member] Research and Development Expense Issuance Of Common Stock Under Pre-Paid Advance Agreement, Shares Issuance Of Common Stock Under Pre-Paid Advance Agreement, Shares Issuance of common stock under PPAs, share Revenue Recognition Revenue Recognition, Revenue Reductions [Policy Text Block] Fair Value Option Fair Value Measurement, Policy [Policy Text Block] Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Other Debt Obligations [Member] Other Debt Obligations [Member] Lessee, Operating Lease, Liability, to be Paid, Year One Nine months ending December 31, 2026 Proceeds from License Fees Received Common Stock Options Common stock options. Common Sock Otions [Member] Prepaid research and development expense. Prepaid Research And Development Expense Prepaid research and development Restructuring liability Restructuring liability Accrued severance Compensation Expense On Issuance Of Director Compensation Compensation Expense On Issuance Of Director Compensation Compensation expense on issuance of director compensation Derivative Instrument [Axis] Derivative Instrument Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Fair Value of Assets Acquired Assets Share-Based Payment Arrangement [Abstract] Sale of Stock [Axis] Sale of Stock Proceeds from issuance of common stock under SEPA Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Revenues, Total Revenues Revenues Accrued research and development expense current. Accrued Research And Development Expense Current Accrued research and development Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Title of 12(b) Security Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Forfeited, Weighted-Average Exercise Price per Share Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Grant Date Fair Value, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Warrant Liability Warrant Liability Warrant liability Balance at December 31, 2025 Balance at March 31, 2026 Collaborative Arrangement and Arrangement Other than Collaborative [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Document Information [Table] Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, Ending Balance, Weighted-Average Exercise Price per Share | $ / shares Outstanding, Beginning Balance, Weighted-Average Exercise Price per Share Fair Value, Recurring and Nonrecurring [Table] Additional Paid-in Capital [Member] Additional Paid-In Capital Statement of Income Location, Balance [Axis] Income Statement Location Trading Symbol Trading Symbol Related Party Transaction [Table] Schedule Of Related Party Transactions By Related Party [Table] Subsequent Event Type [Axis] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term Expected term (in years) Entity Ex Transition Period Entity Ex Transition Period Lessee, Operating Lease, Liability, to be Paid Total future lease payments Total future lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Less: imputed interest Percentage Of Outstanding Common Stock Percentage of outstanding common stock Percentage of outstanding common stock Equity Components [Axis] Equity Components Accounts payble includes related party amounts Accounts Payable, Total Accounts Payable Operating Leases, Future Minimum Payments, Due in Two Years 2023 Equity Component Equity Component [Domain] Asset Class [Axis] Awards Available For Future Issuance Under ESPP Awards Available For Future Issuance Under ESPP Awards available for future issuance under the ESPP Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Expected Future Minimum Payments Under The Non Cancelable Operating Lease Prepaid insurance Prepaid Insurance IPO [Member] IPO [Member] Carolyn Anderson Short. Carolyn Anderson Short [Member] Carolyn Anderson Short Issuance of common stock for Employee Stock Purchase Plan, shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Profits interest incentive plan text block. Profits Interest Incentive Plan [Text Block] Profits Interest Incentive Plan Options Fully Vested On The Modification Date, Number of shares RSUs fully vested on the modification date, number of shares RSUs Fully Vested On The Modification Date, Number of shares RSUs Fully Vested On The Modification Date, Number of shares Increase In Compensation Cost Of Fully Vested Options Increase In Compensation Cost Of Fully Vested Options Increase In Compensation Cost Of Fully Vested Options Maximum [Member] Maximum Unpaid Deferred Financing Cost UnpaidDeferredFinancingCosts Unpaid deferred financing costs Restructuring Costs [Table] Restructuring Costs [Table] Statistical Measurement [Axis] Statistical Measurement Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised, Weighted-Average Exercise Price per Share Common stock value Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Merger and Related Share Consolidation Consolidation, Policy [Policy Text Block] Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total Equity, Including Portion Attributable to Noncontrolling Interest Beginning balance Ending balance Liability to licensor Liability to licensor Liability to licensor Related party amounts Related Party Transaction, Amounts of Transaction Related party amounts Milestone payment received Milestone Payment Received Milestone Payment Received Tax related to net settlement of equity award included in accounts payable and accrued expenses Tax related to net settlement of equity award included in accounts payable and accrued expenses Tax related to net settlement of equity awards included in accounts payable and accrued expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Entity Registrant Name Entity Registrant Name Debt Disclosure [Text Block] Debt Pre-Paid Advance Restructuring Costs [Abstract] Lessee Disclosure [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Other Nonoperating Income (Expense) Total other income Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional Paid in Capital Additional paid-in capital Contractual Exercise Price Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Subsequent Events [Abstract] Accounts Payable and Accrued Liabilities, Current Total Accounts payable and accrued expenses Common stock options. Common Stock Options [Member] Common Stock Options Aggregate potential future gross sale proceeds Proceeds from Issuance of Common Stock Gross proceeds to the Company Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Consolidation Items [Axis] Subsequent Event, Date Subsequent Event, Date Payments for Restructuring Cash payments Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Assets Assets Total assets Property, Plant and Equipment [Table] Schedule Of Property Plant And Equipment [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable, Weighted-Average Remaining Contractual Term (years) Income Statement [Abstract] BA Three One Eight Two [Member] BA Three One Eight Two [Member] BA3182 Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Ozuriftamab Vedotin BA Three Zero Two One [Member] Ozuriftamab Vedotin BA Three Zero Two One [Member] Ozuriftamab vedotin, BA3021 Other CAB Programs [Member] Other CAB Programs [Member] Other CAB Programs Maximum Potential Aggregate Payments Maximum Potential Aggregate Payments Maximum Potential Aggregate Payments Mecbotamab vedotin, BA3011 Mecbotamab Vedotin BA Three Zero One One [Member] Mecbotamab Vedotin BA Three Zero One One [Member] Number of shares sold under transaction Sale of Stock, Number of Shares Issued in Transaction Issuance of common stock, net of issuance costs, shares Stock Issued During Period, Shares, New Issues Common stock shares issued under ESPP PPP Loan P P P Loan [Member] PPP Loan. Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Shares, Vested Number of Shares, Vested Consolidation, Variable Interest Entity, Policy [Policy Text Block] Variable Interest Entities Net loss per common share, diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Schedule of Segment expenses reviewed by the CDMO Schedule of Segment Reporting Information, by Segment [Table Text Block] Operating Segments [Member] Title and Position [Domain] Title of Individual City Area Code City Area Code Change in Fair Value of Pre-Paid Advance Change in Fair Value of Pre-Paid Advance Change in fair value of PPAs liability PrePaid Advance Principal Amount PrePaid Advance Principal Amount Prepaid advance principal amount Aggregate principal amount Debt Instrument, Face Amount Pre-Paid Advance Agreements [Member] Pre-Paid Advance Agreements [Member] Pre-Paid Advance Agreements [Member] Amended License Agreement Second Payment Due Date Amended License Agreement Second Payment Due Date Variable Lease, Cost Variable lease expense Issuance of common stock for Employee Stock Purchase Plan Issuance of common stock for Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Proceeds from issuance of common stock under Employee Stock Purchase Plan Proceeds from issuance of common stock under Employee Stock Purchase Plan Aggregate Gross Proceeds Aggregate Gross Proceeds Aggregate gross proceeds Taxes Related To Net Share Settlement Of Equity Awards Shares Taxes Related To Net Share Settlement Of Equity Awards Shares Taxes related to net share settlement of equity awards, Share Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term (in years) Segment Reporting Information [Line Items] Lessor, Operating Lease, Option to Extend Option to extend the term of the lease Stockholders' Equity Note, Stock Split, Conversion Ratio Organization And Summary Of Significant Accounting Policies [Table] Organization And Summary Of Significant Accounting Policies [Table] Organization and Summary of Significant Accounting Policies. Lease, Cost Total lease expense, net Total lease expense, net Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Gross proceeds to the Company Gross Proceeds From Pre-Paid Advance Agreements Gross Proceeds From Pre-Paid Advance Agreements Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net Property and equipment, net Total Class Of Warrant Exercise Price As Adjusted Class Of Warrant Exercise Price As Adjusted Adjustment of warrants per share Operating Income (Loss) Loss from operations Retained Earnings [Member] Accumulate Deficit Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Non-cash stock-based compensation charges Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate percentage Operating Lease, Liability, Noncurrent Operating lease liabilities, less current portion Fair Value, Inputs, Level 1 [Member] Level 1 Class of Stock [Line Items] Class Of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Amended License Agreement First Payment Due Date Amended License Agreement First Payment Due Date Lease, Cost [Table Text Block] Components of Lease Expense Nonoperating Income (Expense) [Abstract] Other income (expense): Derivative Contract [Domain] Derivative Contract Private Placement of Common Stock. Private Placement of Common Stock [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share Entity Interactive Data Current Entity Interactive Data Current Laboratory Equipment Laboratory Equipment [Member] Laboratory equipment [Member] Shares Available For Future Issuance Under SEPA Shares Available For Future Issuance Under SEPA Shares available for future issuance under the SEPA Statement of Income Location, Balance [Domain] Income Statement Location Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Payments for taxes related to net settlement of equity awards Payments for taxes related to net settlement of equity awards Payments for taxes related to net settlement of equity awards1 Payments For Taxes Related To Net Settlement Of Equity Awards1 Change in Fair Value of Pre-Paid Advance Agreement Change in Fair Value of Pre-Paid Advance Agreement Change in fair value of PPAs Entity Tax Identification Number Entity Tax Identification Number Due to Related Party Due to Related Party Due to related party Fair Value Warrant Liability Fair Value Warrant Liability Warrants License Agreement Payble Amount License Agreement Payble Amount License agreement payble amount Shares Available For Future Conversions Shares Available For Future Conversions Shares available for future conversions of PPAs Proceeds from sale common of stock Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity, Total Local Phone Number Local Phone Number Related Party Transaction [Domain] Description of agreement with related party Description Of Agreement With Related Party Description of agreement with related party. Board Of Directors Board of Directors Chairman [Member] Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Restructuring Costs Restructuring Costs, Total Restructuring Cost Cash payments Payment of financing costs Payments of Financing Costs Payments of Financing Costs, Total Payment of financing costs related to issuance of common stock, PPAs and SEPA Amendment Effective Date Amendment Effective Date Amendment effective date Amended License Agreement First Payable Amount Amended License Agreement First Payable Amount Amended license agreement first payable amount Accounting Policies [Abstract] Schedule of prepaid expenses other current assets table text block. Schedule Of Prepaid Expenses Other Current Assets Table [Text Block] Schedule Of Prepaid Expenses Other Current Assets Allocation of equity-based Compensation for all class B units Allocation of Equity Based Compensation for Class-B units [Table Text Block] Allocation of Equity Based Compensation for Class-B units [Table Text Block] 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Cash and Cash Equivalents [Member] Cash and Cash Equivalents [Member] Class of Stock [Domain] Class of Stock Operating Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments Due Debt Conversion, Description Debt description Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accounts Payable and Accrued Expenses Stock, Class of Stock [Table] Schedule Of Stock By Class [Table] Entity Emerging Growth Company Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Vested and expected to vest, Weighted-Average Remaining Contractual Term (years)